Sat.Oct 12, 2024

article thumbnail

First Melanoma History is Risk Factor for Subsequent Diagnoses Regardless of Race

HCPLive

This analysis indicates that patients with a history of a first melanoma are at risk for subsequent development of melanoma regardless of their race or their ethnicity.

article thumbnail

An elderly male with acute altered mental status and huge ST Elevation

Dr. Smith's ECG Blog

Written by Bobby Nicholson What do you think of this “STEMI”? A man in his 90s with a history of HTN, CKD, COPD, and OSA presented to the emergency department after being found unresponsive at home. With EMS, patient had a GCS of 3 and was saturating 60% on room air. He improved to 100% with the addition of non-rebreather, however remained altered and was intubated by EMS with ketamine and succinylcholine.

STEMI 98
article thumbnail

Increased Dietary Vitamin C Intake May Help Reduce Gout Risk, Study Finds

HCPLive

The analysis of NHANES data revealed an inverse association between dietary vitamin C intake and gout risk.

111
111
article thumbnail

Weekend Warrior Benefits; Time-Restricted Eating and Metabolic Syndrome

Med Page Today

(MedPage Today) -- TTHealthWatch is a weekly podcast from Texas Tech. In it, Elizabeth Tracey, director of electronic media for Johns Hopkins Medicine in Baltimore, and Rick Lange, MD, president of the Texas Tech University Health Sciences Center.

52
article thumbnail

IV Secukinumab Rapidly Improved Clinical Responses in Psoriatic Arthritis

HCPLive

Results from INVIGORATE-2 showed IV secukinumab led to improved clinical measures of PsA, with a similar safety profile to subcutaneous secukinumab.

75
article thumbnail

Secukinumab, Adalimumab Have Distinct Advantages for Treating PsA

HCPLive

Secukinumab is best for severe skin involvement, while adalimumab improves synovitis in PsA. Both are effective, but larger studies are needed for long-term outcomes.

article thumbnail

Long-term Opioids for Fibromyalgia Linked to Depression, Sleep Issues

HCPLive

Research from Spain suggests long-term opioid use to treat fibromyalgia pain significantly raises the risk of depression, anxiety and sleep disorders in patients.